ELAB -
PMGC Holdings Inc. Common Stock
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| 4.63 0.05 (1.08%) |
--- |
--- |
0.0 (0.0%) |
0.0 (0.0%) |
-0.09 (-1.89%) |
--- |
0.0 (0.0%) |
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 0.0
- VWAP:
- 4.68
- RVol:
Events
| Period |
Kind |
Movement |
Occurred At |
Related News
NorthStrive® Companies Inc. Advises on the Successful Closing of the Acquisition of Indarg Engineering, Inc., a California-Based Precision CNC Manufacturer
Oct 30, 2025 23:30
NorthStrive® Companies Inc. Advises on the Successful Closing of the Acquisition of Indarg Engineering, Inc., a California-Based Precision CNC Manufacturer
Oct 30, 2025 23:30
Univest Securities, LLC Announces Closing of $1.67 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)
Aug 25, 2025 21:00
PMGC Holdings Inc. Announces $1.67 Million in Gross Proceeds from Warrant Inducement with Institutional Investors Priced At-The Market Under Nasdaq Rules
Aug 22, 2025 17:48
PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets
Jul 30, 2025 11:45
PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC
Jul 18, 2025 16:53
PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024
Jul 10, 2025 12:30
PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue
Jun 24, 2025 12:30
Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment
Apr 24, 2025 12:00
PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules
Mar 21, 2025 18:41